Dai, Chun-Ling
Li, Hengchang
Hu, Xin
Zhang, Jin
Liu, Fei
Iqbal, Khalid
Gong, Cheng-Xin http://orcid.org/0000-0001-5004-7876
Funding for this research was provided by:
New York State Office for People with Developmental Disabilities (0601)
Guangzhou First People’s Hospital (Scholarship)
Article History
Received: 24 February 2020
Revised: 9 April 2020
Accepted: 1 May 2020
First Online: 26 May 2020
Compliance with Ethical Standards
:
: K.I. serves on the scientific advisory board of AXON Neuroscience, has received research grants from Ever NeuroPharma and Signum Biosciences, and holds several patents on treatment of Alzheimer’s disease and related conditions. C.-X.G. serves on the scientific advisory board of Alectos Therapeutics. K.I., F.L., and C.-X.G hold a patent on intranasal insulin administration for the minimization of anesthesia-induced memory loss.
: The housing, breeding, and animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the New York State Institute for Basic Research in Developmental Disabilities and were in accordance with the PHS Policy on Human Care and Use of Laboratory animals (revised March 15, 2010).
: Not applicable.
: Not applicable.
: Not applicable.